Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure (Q33735342)

29 July 2017

title

Use of nesiritide before and after publications suggesting drug-related risks in patients with acute decompensated heart failure (English)

1 reference

acute decompensated heart failure

29 July 2017

0 references

1 reference

Paul J Hauptman

1

1 reference

29 July 2017

Mark A Schnitzler

series ordinal

2

1 reference

29 July 2017

Jason Swindle

series ordinal

3

1 reference

29 July 2017

Thomas E Burroughs

series ordinal

4

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

The Journal of the American Medical Association

29 July 2017

published in

1 reference

29 July 2017

volume

296

1 reference

29 July 2017

issue

15

1 reference

29 July 2017

page(s)

1877-1884

1 reference

The impact of clinical trials on the use of hormone replacement therapy. A population-based study

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

National patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Evidence-based prescribing of antibiotics for children: role of socioeconomic status and physician characteristics

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Estrogen plus progestin and the risk of coronary heart disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

The striking effect of the Heart Outcomes Prevention Evaluation (HOPE) on ramipril prescribing in Ontario.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Attitudes and behaviour of general practitioners and their prescribing costs: a national cross sectional survey

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Effect of local medical opinion leaders on quality of care for acute myocardial infarction: a randomized controlled trial

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

The development of positive inotropic agents for chronic heart failure: how have we gone astray?

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

The rise and fall of Natrecor for congestive heart failure: implications for drug policy.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Assessing potential risks and evaluating expected benefits.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Differences in antibiotic prescribing among physicians, residents, and nonphysician clinicians

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Time trends in the use of beta-blockers and other pharmacotherapies in older adults with congestive heart failure

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Impact of clinical trial results on national trends in alpha-blocker prescribing, 1996-2002.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Synergy between publication and promotion: comparing adoption of new evidence in Canada and the United States

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Inotropic infusions for chronic congestive heart failure: medical miracles or misguided medicinals?

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Nesiritide — Not Verified

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2840641

Intermittent 6-month low-dose dobutamine infusion in severe heart failure: DICE multicenter trial

30 October 2018

1 reference

12 December 2020

Management of heart failure among very old persons living in long-term care: has the voice of trials spread? The SAGE Study Group

1 reference

12 December 2020

Between Scylla and Charybdis: The choice of inotropic agent for decompensated heart failure

1 reference

12 December 2020

Medical decision making in antipsychotic drug choice for schizophrenia

1 reference

12 December 2020

Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure

1 reference

12 December 2020

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

12 December 2020

Digoxin use and digoxin toxicity in the post-DIG trial era

1 reference

12 December 2020

Impact of the Coronary Drug Project findings on clinical practice

1 reference

12 December 2020

The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study

1 reference

12 December 2020

Heart failure between 1986 and 1994: Temporal trends in drug-prescribing practices, hospital readmissions, and survival at an academic medical center

1 reference

12 December 2020

Temporal trends in pharmacotherapy for congestive heart failure at an academic medical center: 1990-1995

1 reference

12 December 2020

Trends in the use of pharmacotherapies for acute myocardial infarction among physicians who design and/or implement randomized trials versus physicians in routine clinical practice: the MILIS-TIMI experience. Multicenter Investigation on Limitation

1 reference

12 December 2020

Identifiers

DOI

10.1001/JAMA.296.15.1877

1 reference

29 July 2017

1 reference

29 July 2017

1 reference